|
Kubo T., Gimeno J.R., Bahl A., Steffensen U., Steffensen M., Osman E., Thaman R., Mogensen J., Elliott P.M., Doi Y., McKenna W.J. Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype. Journal of the American College of Cardiology. 26 June 2007. 49:2419-2426. 10.1016/j.jacc.2007.02.061
AÑO: 2007; IF: 11.054
|
|
Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, García-Honrubia A, Pérez I, Fernández X, de Nicolas R, de la Morena G, Payá E, Yagüe J, Egido J. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007 Dec 18;50(25):2399-403. PubMed PMID: 18154965.
AÑO: 2007; IF: 11.054
|
|
Marín F., Gimeno J.R., Martínez J.G., Monserrat L. Response [4]. Revista Espanola de Cardiologia. July 2007. 60:785. 10.1157/13108288
AÑO: 2007; IF: 2.207
|
|
Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish. PubMed PMID: 16790196.
AÑO: 2006; IF: 2.176
|
|
Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S, Tome Esteban MT, McKenna WJ. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart. 2006 Jun;92(6):785-91. doi: 10.1136/hrt.2005.068577. Epub 2005 Oct 10. PubMed PMID: 16216855; PubMed Central PMCID: PMC1860645.
AÑO: 2006; IF: 5.7
|